
Penn AI RNA Drug Development Platform Cuts Timelines from 10 Years to 1
University of Pennsylvania's Penn AI RNA drug development platform leverages cloud AI to reduce timelines from 10 years to 1 year. This accelerates vaccines and therapies, boosting AWS revenues 17% to $25B in Q1 2024.










